Neovasc Inc. (TSE:NVC – Get Free Report) (NASDAQ:NVCN) traded up 2.3% during trading on Monday . The company traded as high as C$1.82 and last traded at C$1.78. 46,869 shares traded hands during trading, a decline of 58% from the average session volume of 111,876 shares. The stock had previously closed at C$1.74.
Neovasc Price Performance
The stock has a 50-day moving average price of C$1.78.
Neovasc Company Profile
Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.
Further Reading
- Five stocks we like better than Neovasc
- NYSE Stocks Give Investors a Variety of Quality Options
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- The Basics of Support and Resistance
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Evaluate a Stock Before Buying
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.